Cible Skin

Cible Skin is a French luxury skincare brand founded in 2015 by Pharmaceutical Doctor Raphaël Aknin and entrepreneur Jean Ginefri, with the mission of creating a luxury cosmetics brand that uses the patented science of cell immunity and rejuvenation to produce the most potent results for customers around the world.
Region
Asia,
Europe
Sectors
Lifestyle
Investment
2024 - Active
Verlinvest contact
Raphael Thiolon

About

Cible Skin takes a rigorous, research-backed approach to developing high-quality formulations, made in France with the best natural, clean, active ingredients, and offers skincare products including cleansers, serums, and moisturizers. The brand also offers a range of exclusive treatments at its flagship clinic in Paris, La Maison Cible Skin, providing customers with both a luxurious experience and personalized, technical and scientific guidance through their skincare journey. 

Cible Skin draws on the expertise of its Scientific Committee, chaired by Co-Founder Dr. Raphaël Aknin, which combines decades of experience in regenerative medicine and immunological science to preserve the health, equilibrium, and beauty of the skin through the innovation of immuno-cosmetics. This clinically proven method boosts the immune system of skin cells to protect, regenerate and repair the skin, with powerful anti-aging, anti-imperfect, antioxidant, and ultra-moisturizing results. 

In less than two years, the brand has gained a cult following amongst its customers, which include top celebrities, with La Maison Cible Skin named “the world’s best beauty clinic for anti-ageing treatments” by Forbes in 2023. Beyond its home market of France, Cible is growing rapidly, achieving multi-million dollars sales in China after launching there in March 2023. 

Verlinvest invested in February 2024 to support the company’s unique immuno-cosmetic product development and continued global expansion.